MaxCyte Inc’s filing revealed that its Director Erck Stanley C unloaded Company’s shares for reported $0.18 million on Nov 01 ’24. In the deal valued at $3.72 per share,47,689 shares were sold. As a result of this transaction, Erck Stanley C now holds 269,118 shares worth roughly $0.87 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Johnston John Joseph sold 3,000 shares, generating $11,166 in total proceeds. Upon selling the shares at $3.72, the Director now owns 141,950 shares.
Before that, Erck Stanley C sold 26,082 shares. MaxCyte Inc shares valued at $98,590 were divested by the Director at a price of $3.78 per share. As a result of the transaction, Erck Stanley C now holds 269,118 shares, worth roughly $0.87 million.
Craig Hallum initiated its MaxCyte Inc [MXCT] rating to a Buy in a research note published on November 29, 2023; the price target was $7. William Blair began covering MXCT with “an Outperform” recommendation on August 24, 2021. Wedbush started covering the stock on August 24, 2021. It rated MXCT as “an Outperform”.
Price Performance Review of MXCT
On Monday, MaxCyte Inc [NASDAQ:MXCT] saw its stock fall -5.56% to $3.23. Over the last five days, the stock has lost -9.78%. MaxCyte Inc shares have fallen nearly -31.28% since the year began. Nevertheless, the stocks have fallen -17.18% over the past one year. While a 52-week high of $5.55 was reached on 01/12/24, a 52-week low of $3.23 was recorded on 11/18/24. SMA at 50 days reached $3.77, while 200 days put it at $4.20.
Levels Of Support And Resistance For MXCT Stock
The 24-hour chart illustrates a support level at 3.15, which if violated will result in even more drops to 3.06. On the upside, there is a resistance level at 3.38. A further resistance level may holdings at 3.53. The Relative Strength Index (RSI) on the 14-day chart is 34.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.40%. Stochastics %K at 15.03% indicates the stock is a buying.
How much short interest is there in MaxCyte Inc?
A steep rise in short interest was recorded in MaxCyte Inc stocks on 2024-10-31, dropping by -0.61 million shares to a total of 3.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 3.85 million shares. There was a decline of -18.81%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 24, 2021 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $18 price target.
